Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Metastatic …
M Jamal-Hanjani, J Spicer - Clinical Cancer Research, 2012 - AACR
Brain metastases are a common and devastating consequence of disease progression in
patients with non–small cell lung cancer (NSCLC). The epidermal growth factor receptor …
patients with non–small cell lung cancer (NSCLC). The epidermal growth factor receptor …
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to …
M Jamal-Hanjani, J Spicer - Clinical Cancer Research, 2012 - kclpure.kcl.ac.uk
Brain metastases are a common and devastating consequence of disease progression in
patients with non-small cell lung cancer (NSCLC). The epidermal growth factor receptor …
patients with non-small cell lung cancer (NSCLC). The epidermal growth factor receptor …
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the …
M Jamal-Hanjani, J Spicer - … Cancer Research: an Official Journal of …, 2011 - europepmc.org
Brain metastases are a common and devastating consequence of disease progression in
patients with non-small cell lung cancer (NSCLC). The epidermal growth factor receptor …
patients with non-small cell lung cancer (NSCLC). The epidermal growth factor receptor …
[PDF][PDF] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer …
M Jamal-Hanjani, J Spicer - brain, 2011 - scholar.archive.org
Brain metastases are a common and devastating consequence of disease progression in
patients with non–small cell lung cancer (NSCLC). The epidermal growth factor receptor …
patients with non–small cell lung cancer (NSCLC). The epidermal growth factor receptor …
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Metastatic …
M Jamal-Hanjani, J Spicer - Clinical Cancer Research, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Brain metastases are a common and
devastating consequence of disease progression in patients with non–small cell lung cancer …
devastating consequence of disease progression in patients with non–small cell lung cancer …
[引用][C] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor―Mutant Non―Small Cell Lung Cancer …
M JAMAL-HANJANI, J SPICER - Clinical cancer research …, 2012 - pascal-francis.inist.fr
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal
Growth Factor Receptor―Mutant Non―Small Cell Lung Cancer Metastatic to the Brain CNRS …
Growth Factor Receptor―Mutant Non―Small Cell Lung Cancer Metastatic to the Brain CNRS …
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the …
M Jamal-Hanjani, J Spicer - Clinical cancer research: an …, 2012 - pubmed.ncbi.nlm.nih.gov
Brain metastases are a common and devastating consequence of disease progression in
patients with non-small cell lung cancer (NSCLC). The epidermal growth factor receptor …
patients with non-small cell lung cancer (NSCLC). The epidermal growth factor receptor …